首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Therapeutic Advances In Respiratory Disease

Therapeutic Advances In Respiratory Disease杂志,由SAGE Publications Ltd出版,于2007年创刊,1 issue/year,出版语言English,ISSN:1753-4658,E-ISSN:1753-4666。

投稿咨询
Therapeutic Advances In Respiratory Disease
Therapeutic Advances In Respiratory Disease
Therapeutic Advances In Respiratory Disease
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.2
CiteScore
5.1
期刊收录
SCI、SCIE

Therapeutic Advances In Respiratory Disease(中文译名:《呼吸系统疾病的治疗进展》),ISSN:1753-4658,EISSN:1753-4666,是SAGE Publications Ltd出版的国际性学术期刊,创刊于2007年,以1 issue/year形式稳定发行,2026年总发文量约97篇。该刊采用OA开放访问,学科归属为RESPIRATORY SYSTEM。该刊是医学、呼吸系统领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.2,2025年期刊CiteScore为5.1,2025年期刊自引率约3.1%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Therapeutic Advances In Respiratory Disease长期聚焦医学、呼吸系统及相关产业的技术应用前沿,平均审稿周期15 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、呼吸系统领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Italy、England、GERMANY (FED REP GER)、Canada、Spain等为核心发文国家与地区;ASTRAZENECASUNGKYUNKWAN UNIVERSITY (SKKU)、CAPITAL MEDICAL UNIVERSITY、CENTRAL SOUTH UNIVERSITY、CHINA MEDICAL UNIVERSITY、GUANGZHOU MEDICAL UNIVERSITY、LAVAL UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
RESPIRATORY SYSTEM 呼吸系统
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
RESPIRATORY SYSTEM 呼吸系统
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
RESPIRATORY SYSTEM 呼吸系统
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RESPIRATORY SYSTEM SCIE Q2 43 / 107

60.3

学科:RESPIRATORY SYSTEM SCIE Q2 38 / 107

64.95

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RESPIRATORY SYSTEM SCIE Q2 32 / 100

68.5

学科:RESPIRATORY SYSTEM SCIE Q2 32 / 101

68.81


中国学者近期发文

1
Spontaneous pneumothorax-associated with genetic disorder

Author:Chen, Xianmeng; Ryu, Jay H.; Hu, Xiaowen

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261437339

2
Discriminating nodular pulmonary alveolar proteinosis from lung adenocarcinoma with radiomic model and multimodal mode

Author:Chang, Qing; Zhang, Huaizhe; Xu, Ning; Mao, Ruolin; Li, Mengnan; Zhang, Hai; Chen, Yuqing; Sun, Jianqi; Li, Feng

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261436223

3
The role of transbronchial lung cryobiopsy in multidisciplinary discussion for interstitial lung diseases: a dual-center retrospective stud

Author:Liu, Qi; Wang, Ting; Chang, Qing; Xu, Ning; Mao, Ruolin; Li, Mengnan; Sun, Ding; Chen, Yuqing; Zhang, Hai; Zhang, Hongying; Li, Feng

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261438213

4
Genetic strategies for negative or variant of uncertain significance findings in exome sequencing in hereditary bronchiectasis: a case serie

Author:Zhou, Wangji; Li, Yixuan; Chen, Qiaoling; Wang, Yaqi; Li, Aoyue; Lu, Wanqing; Li, Xiaogang; Xu, Kai-Feng; Zhang, Xue; Liu, Yaping; Tian, Xinlun

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261422041

5
Pulmonary intravascular large B-cell lymphoma misdiagnosed as allergic pneumonia: a case report and literature revie

Author:Deng, Hao; Guo, Bingpeng; Chen, Gengjia; Li, Qiexinhao; Feng, Du; Yang, Chuoqi; Zhong, Xiaolu; Luo, Qun; Li, Shiyue; Han, Qian

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261424374

6
Optimizing clinical strategies for nutritional and immune indices prediction of chronic lung diseases: a cross-sectional study from NHANES 2007-201

Author:He, Song; Chen, Cong; Hao, Jianqi; Shu, Yueli; Yu, Cheng; Liu, Xiaojun; Wu, Xiaoqing; Luo, Nanzhi; Zhou, Wenjing; Zha, Zhengyu

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261432503

7
Gastroesophageal reflux-induced cough: the positive feedback loop of microaspiration and neurogenic inflammatio

Author:Rui, Yang; Yi, Fang; Lin, Ming-Tong; Lu, Hankun; Chen, Yan; Zhu, Hong; Chen, Zhe; Shen, Bo

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261435858

8
Bronchoscopic occlusion for central bronchopleural fistula after pulmonary resection: material selection and risk model for long-term prognosi

Author:Liu, Jiaping; Cui, Lixin; Zou, Heng; Wang, Hongwu

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261431091

9
The effectiveness of non-invasive positive pressure ventilation combined with rehabilitation training in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysi

Author:Li, Shuqin; Yang, Xun; Wu, Ying; Zhu, Jing; Feng, Mei; Wu, Xiaoling

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666261424364

10
Subglottic cysts as an uncommon cause of upper airway obstruction: a 12-year retrospective stud

Author:Zhang, Guangli; Wang, Chongjie; Tian, Xiaoyin; Luo, Jian; Li, Yuanyuan; Suo, Fengtao; Zhang, Li; Gu, Ruixue; Xie, Xiaohong; Luo, Zhengxiu

Journal: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE. 2026; Vol. 20, Issue , pp. -. DOI: 10.1177/17534666251410167


在线咨询

Therapeutic Advances In Respiratory Disease

国际简称:THER ADV RESPIR DIS参考译名:呼吸系统疾病的治疗进展

年发文量:97 CiteScore:5.1 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:72.16%

杂志社联系方式:1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP

Therapeutic Advances In Respiratory Disease